IKS Health Expands US Healthcare Footprint with $565-Million TruBridge Acquisition

IKS Health, a leading healthcare technology services company, has agreed to acquire US-based healthcare technology firm TruBridge Inc. for a total consideration of up to $565 million. This strategic move marks the company’s largest acquisition to date and a significant push into rural and community hospital technology.

Strategic Rationale Behind the Acquisition

The acquisition will see IKS Health buy 100 percent of TruBridge through its US arm Inventurus Knowledge Solutions Inc., with the deal aimed at strengthening IKS Health’s footprint across electronic health records (EHR) and revenue cycle management (RCM) for smaller hospitals in the US. Under the terms of the agreement, TruBridge shareholders will receive $26.25 in cash per share, valuing the Nasdaq-listed company at an enterprise value of about $557 million.

IKS Health believes that the acquisition will help diversify its business into a sticky, recurring SaaS-led EHR segment, while allowing it to offer an integrated “system of record plus system of action” platform combining TruBridge’s EHR backbone with IKS Health’s AI-driven care-enablement solutions. Healthcare Technology is a rapidly evolving field, and this acquisition will enable IKS Health to stay ahead of the curve.

Benefits of the Acquisition

By welcoming TruBridge, IKS Health is extending its proven, clinician-first experience to the vital rural and community hospital market. The combined entity will serve over 2,000 healthcare organisations and 150,000 clinicians, with opportunities for cross-selling care-enablement solutions into TruBridge’s installed base. This will not only enhance the company’s revenue stream but also provide better services to its clients. To know more about Revenue Cycle Management, visit our website.

TruBridge serves over 700 community and critical-access hospitals across the US and reported revenue of $347 million in calendar year 2025, according to regulatory disclosures. The company has a client base of more than 1,500 healthcare organisations and generates a significant portion of revenue from long-term software and service contracts. This acquisition will provide IKS Health with a strong foothold in the US healthcare market and enable it to compete with other major players in the industry.

Financing the Deal

The acquisition will be funded primarily through debt, with IKS Inc. securing committed financing of up to $670 million from a consortium led by Citibank, JPMorgan Chase and Deutsche Bank. The funding package includes a $610-million term loan, a $40-million secondary term loan, and a $20-million revolving credit facility. Initial leverage is expected to be around three times EBITDA of the combined entity, according to the investor presentation.

IKS has said the deal is expected to be EPS and PAT accretive from FY27, aided by TruBridge’s adjusted EBITDA margin of about 20 percent and the elimination of public-company costs post-delisting. This acquisition is a strategic move by IKS Health to expand its business and increase its revenue. To know more about Indian Healthcare Companies, visit our website.

Future Prospects

The TruBridge deal builds on IKS Health’s earlier acquisition of AQuity Solutions, which expanded its revenue cycle and clinical documentation services. The company has highlighted AQuity as a successful integration, with cross-selling accelerating within three quarters and margins expanding meaningfully thereafter. Management believes the TruBridge transaction follows a similar playbook but at far greater scale, while also adding proprietary EHR assets—a first for IKS Health.

The deal was announced post-market hours. On Thursday, shares of IKS Health gained 0.55 percent on BSE to close at Rs.1435.40, while the benchmark Sensex declined 1.09 percent to end at 77,664 points. This acquisition is a significant move by IKS Health and is expected to have a positive impact on the company’s stock price. To know more about Stock Market News, visit our website.

Conclusion

In conclusion, the acquisition of TruBridge by IKS Health is a strategic move that will enable the company to expand its footprint in the US healthcare market. The deal will provide IKS Health with a strong foothold in the rural and community hospital market and enable it to offer a comprehensive range of services to its clients. With the acquisition expected to be EPS and PAT accretive from FY27, IKS Health is poised for significant growth in the coming years. To know more about Healthcare Market Trends, visit our website.